SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharma receives US FDA approval for generic Crestor

20 Jul 2016 Evaluate

Sun Pharmaceutical Industries and its subsidiaries or associate companies have received final approval from US FDA for its Abbreviated New Drug Application (ANDA) for generic version of Crestor, Rosuvastatin Calcium tablets 5 mg (base), 10 mg (base), 20 mg (base) and 40 mg (base). These Rosuvastatin Calcium tablets are therapeutic equivalents of IPR Pharmaceuticals, Inc’s Crestor tablets.

As per IMS MAT May 2016, these tablets have annual sales of approximately $ 6.8 billion in the US. These tablets are indicated for the treatment of adult patients with Hypertriglyceridemia, Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia) and adult patients with Homozygous Familial Hypercholesterolemia.

Sun Pharma is the world's fifth largest specialty generic pharmaceutical company and India's top pharmaceutical company. A vertically integrated business, economies of scale and an extremely skilled team enable us to deliver quality products in a timely manner at affordable prices. It provides high-quality, affordable medicines trusted by customers and patients in over 150 countries across the world.

Sun Pharma Inds. Share Price

1875.35 28.05 (1.52%)
11-May-2026 12:29 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1875.35
Dr. Reddys Lab 1299.30
Cipla 1317.65
Zydus Lifesciences 944.35
Lupin 2267.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×